Li Long

This inventor holds 14 USPTO granted patents and 6 published patent applications, plus 4 CIPO patents and 11 EPO patents. Top assignees: Novartis Vaccines & Diagnostics, Gmbh, Five Prime Therapeutics, Inc., Xoma Technology Ltd.. Active years: 2011-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Li Long. Retrieved from https://idiyas.com/inventor/li-long

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 6)

% Patents Active = 85.7

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 11 (Patent Applications = 13)

Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 145(Granted Patents)

Location History:

Hercules, CA (US) (2012 - 2014)
Lafayette, CA (US) (2011 - 2021)
Emeryville, CA (US) (2019 - 2024)

Company Filing History:

6 out of 245

Novartis Vaccines & Diagnostics, Gmbh

patents

5 out of 77

Five Prime Therapeutics, Inc.

Eureka Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2011-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11981742 - Antibody agents specific for human CD19 and uses thereof (2024-05-14),

2. 11034759 - Humanized M-CSF specific monoclonal antibodies, kits, and uses thereof (2021-06-15),

3. 10537611 - Methods of treating lung cancer (2020-01-21),

4. 10301388 - Antibody agents specific for human CD19 and uses thereof (2019-05-28),

5. 10016484 - Methods of treating lung cancer (2018-07-10),

6. 10011658 - Constructs targeting AFP peptide/MHC complexes and uses thereof (2018-07-03),

7. 9926371 - M-CSF specific monoclonal antibody and uses thereof (2018-03-27),

8. 9522186 - M-CSF specific monoclonal antibody and uses therof (2016-12-20),

9. 9079956 - M-CSF specific monoclonal antibody and uses thereof (2015-07-14),

10. 8951972 - FGFR1 extracellular domain combination therapies for lung cancer (2015-02-10),

11. 8637032 - Antagonist anti-CD40 monoclonal antibodies and methods for their use (2014-01-28),

12. 8277810 - Antagonist anti-CD40 antibodies (2012-10-02),

13. 8183207 - Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molecules (2012-05-22),

14. 8080246 - Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules (2011-12-20),

Title: The Innovative Journey of Inventor Li Long

Introduction: Li Long, a pioneering inventor based in Lafayette, CA, has made significant contributions to the world of technology through her groundbreaking inventions and patents.

Latest Patents: Li Long holds several patents in the field of renewable energy technologies, including a recent patent for a solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the tech industry, Li Long has worked for leading companies such as SolarTech Innovations and Clean Energy Solutions, where she spearheaded projects that revolutionized the way we harness solar power.

Collaborations: Li Long is known for her collaborative spirit, having partnered with renowned researchers from Stanford University and Lawrence Berkeley National Laboratory on projects aimed at advancing sustainable energy solutions.

Conclusion: Li Long's passion for innovation and commitment to creating a more sustainable future have solidified her reputation as a trailblazing inventor in the field of renewable energy. Her work continues to inspire the next generation of inventors to push the boundaries of what is possible in the world of technology.

Profile summary based on public USPTO records.